• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

    5/13/24 8:31:53 AM ET
    $BUR
    $CIM
    $FTRE
    $KEP
    Finance: Consumer Services
    Finance
    Real Estate Investment Trusts
    Real Estate
    Get the next $BUR alert in real time by email

    U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday.

    Shares of Seritage Growth Properties (NYSE:SRG) fell sharply in today's pre-market trading after the company reported a loss for the first quarter.

    The company posted a quarterly loss of 36 cents per share, versus a year-ago loss of $1.13 per share, according to data from Benzinga Pro.

    Seritage Growth Properties shares dipped 23.6% to $7.12 in pre-market trading.

    Here are some big stocks recording losses in today's pre-market trading session.

    • Vitesse Energy, Inc. (NYSE:VTS) shares declined 10.2% to $21.64 in pre-market trading. Vitesse Energy, last week, posted downbeat quarterly earnings.
    • Chimera Investment Corporation (NYSE:CIM) shares fell 6.3% to $4.32 in pre-market trading. Chimera Investment announced a 1-for-3 reverse stock split.
    • Fortrea Holdings Inc. (NASDAQ:FTRE) shares declined 6% to $31.06 in pre-market trading after the company reported soft first-quarter results and cut its revenue outlook.
    • Mesoblast Ltd (NASDAQ:MESO) shares declined 3.7% to $7.09 in pre-market trading after gaining around 3% on Friday.
    • Mind Medicine (MindMed) Inc (NASDAQ:MNMD) shares fell 3.7% to $8.92 in pre-market trading.
    • MKS Instruments Inc (NASDAQ:MKSI) shares declined 3.4% to $126.02 in pre-market trading as the company reported a proposed private offering of $1 billion of convertible senior notes.
    • Korea Electric Power Corporation (NYSE:KEP) shares fell 3.3% to $7.29 in pre-market trading after declining 7% on Friday.
    • PENN Entertainment Inc (NASDAQ:PENN) shares slipped 3% to $15.61 in pre-market trading. B of A Securities analyst Shaun Kelley downgraded PENN Entertainment from Buy to Neutral and lowered the price target from $28 to $17.5.
    • Burford Capital Limited (NYSE:BUR) shares slipped 2.5% to $15.05 in pre-market trading after reporting first-quarter results.

    Now Read This: Tencent Music Entertainment, StoneCo And 3 Stocks To Watch Heading Into Monday

    Don't forget to check out our premarket coverage here

    Get the next $BUR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BUR
    $CIM
    $FTRE
    $KEP

    CompanyDatePrice TargetRatingAnalyst
    Korea Electric Power Corporation
    $KEP
    3/31/2026Buy → Neutral
    BofA Securities
    Burford Capital Limited
    $BUR
    3/30/2026$4.75Outperform → Neutral
    Wedbush
    Fortrea Holdings Inc.
    $FTRE
    3/9/2026$15.00Hold → Buy
    TD Cowen
    PENN Entertainment Inc.
    $PENN
    3/5/2026$21.00Hold → Buy
    The Benchmark Company
    Burford Capital Limited
    $BUR
    2/20/2026$14.00Outperform
    Wedbush
    Burford Capital Limited
    $BUR
    2/18/2026Buy
    BofA Securities
    MKS Inc.
    $MKSI
    1/22/2026$200.00 → $230.00Buy
    TD Cowen
    MKS Inc.
    $MKSI
    1/22/2026$210.00 → $260.00Buy
    Needham
    More analyst ratings

    $BUR
    $CIM
    $FTRE
    $KEP
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Seritage Growth Properties

    SCHEDULE 13G/A - Seritage Growth Properties (0001628063) (Subject)

    4/7/26 7:00:09 AM ET
    $SRG
    Real Estate
    Finance

    MKS Inc. filed SEC Form 8-K: Leadership Update

    8-K - MKS INC (0001049502) (Filer)

    4/6/26 8:29:07 AM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    SEC Form DEFA14A filed by Burford Capital Limited

    DEFA14A - Burford Capital Ltd (0001714174) (Filer)

    4/2/26 6:32:36 AM ET
    $BUR
    Finance: Consumer Services
    Finance

    $BUR
    $CIM
    $FTRE
    $KEP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials

    Highlights: Designed to transform clinical trial operations for sponsors, sites and study teamsPersona driven, AI-powered solutions automate workflows and streamline oversight to help improve trial speed, predictability and qualityBuilds on Fortrea's flagship platform Xcellerate® to deliver near-real-time, role-based insights DURHAM, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global clinical research organization (CRO), today unveiled Fortrea Intelligent Technology™(FIT), a suite of innovative technology solutions designed to transform clinical trial operations. By integrating persona-driven, AI-powered solutions that automate workflows, streamline oversig

    4/7/26 7:00:00 AM ET
    $FTRE
    Medical Specialities
    Health Care

    Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter

    Strong growth in February/March following January seasonality Net revenue approaches US$100M since launch NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced Ryoncil® (remestemcel-L-rknd) net sales were US$30.3 million for the quarter ended March 31, 2026.1 Strong sales in February and March offset holiday seasonality in January. Revenue generated during this first year of Ryoncil® launch approaches US$100 million. Ryoncil® revenue strengthens Mesoblast's balance sheet and supports label extension and late-stage blockbuster programs. Ryoncil® is the first mesench

    4/6/26 9:03:58 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    PENN Entertainment to Report First Quarter Results and Host Conference Call and Webcast on April 23

    PENN Entertainment, Inc. (NASDAQ:PENN) announced today that it will release its 2026 first quarter financial results at 7:00 a.m. ET on Thursday, April 23, 2026, followed by a conference call and simultaneous webcast at 8:00 a.m. ET. Both the call and webcast are open to the general public. The conference call number is 785-424-1699 (conference ID: PENN); please call five minutes in advance to ensure that you are connected prior to the presentation. Interested parties may also access the live call at www.pennentertainment.com; allow 15 minutes to register, download, and install any necessary software. Questions and answers will be reserved for call-in analysts and investors. A replay of t

    3/30/26 2:31:00 PM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    $BUR
    $CIM
    $FTRE
    $KEP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Scaccetti Jane bought $120,720 worth of shares (8,000 units at $15.09), increasing direct ownership by 7% to 117,153 units (SEC Form 4)

    4 - PENN Entertainment, Inc. (0000921738) (Issuer)

    3/3/26 8:30:03 AM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    EVP and CFO Hendrix Felicia bought $100,874 worth of shares (7,315 units at $13.79), increasing direct ownership by 7% to 119,448 units (SEC Form 4)

    4 - PENN Entertainment, Inc. (0000921738) (Issuer)

    11/24/25 9:00:12 AM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    Director Handler David A bought $285,000 worth of shares (20,000 units at $14.25), increasing direct ownership by 6% to 362,941 units (SEC Form 4)

    4 - PENN Entertainment, Inc. (0000921738) (Issuer)

    11/18/25 4:47:05 PM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    $BUR
    $CIM
    $FTRE
    $KEP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by O Leary Dan

    4 - Vitesse Energy, Inc. (0001944558) (Issuer)

    4/1/26 4:11:10 PM ET
    $VTS
    Oil & Gas Production
    Energy

    SEC Form 4 filed by Cree Brian

    4 - Vitesse Energy, Inc. (0001944558) (Issuer)

    4/1/26 4:08:29 PM ET
    $VTS
    Oil & Gas Production
    Energy

    SEC Form 4 filed by Henderson James P

    4 - Vitesse Energy, Inc. (0001944558) (Issuer)

    4/1/26 4:05:46 PM ET
    $VTS
    Oil & Gas Production
    Energy

    $BUR
    $CIM
    $FTRE
    $KEP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Korea Electric Power Corp downgraded by BofA Securities

    BofA Securities downgraded Korea Electric Power Corp from Buy to Neutral

    3/31/26 9:38:45 AM ET
    $KEP
    Electric Utilities: Central
    Utilities

    Burford Capital downgraded by Wedbush with a new price target

    Wedbush downgraded Burford Capital from Outperform to Neutral and set a new price target of $4.75

    3/30/26 8:16:51 AM ET
    $BUR
    Finance: Consumer Services
    Finance

    Fortrea upgraded by TD Cowen with a new price target

    TD Cowen upgraded Fortrea from Hold to Buy and set a new price target of $15.00

    3/9/26 8:42:40 AM ET
    $FTRE
    Medical Specialities
    Health Care

    $BUR
    $CIM
    $FTRE
    $KEP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Vitesse Energy Inc.

    SC 13D/A - Vitesse Energy, Inc. (0001944558) (Subject)

    12/17/24 6:45:44 PM ET
    $VTS
    Oil & Gas Production
    Energy

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Mind Medicine (MindMed) Inc.

    SC 13G/A - Mind Medicine (MindMed) Inc. (0001813814) (Subject)

    11/14/24 4:05:16 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    $BUR
    $CIM
    $FTRE
    $KEP
    Leadership Updates

    Live Leadership Updates

    View All

    Vitesse Energy Announces Leadership Transition, With Jamie Benard to Join as President and Chief Executive Officer

    Vitesse Energy, Inc. (NYSE:VTS) ("Vitesse," "we," or the "Company") today announced that its Board of Directors has appointed Jamie Benard as President and Chief Executive Officer, effective May 1, 2026. Mr. Benard's appointment represents the culmination of a thorough succession planning process that will position the Company for continued long-term strategic execution and success. "We are delighted to welcome Jamie Benard to the Vitesse team. Jamie brings proven leadership and a strong record of success. The Board believes this transition will accelerate our strategic priorities and drive long‑term value for stockholders," said Dan O'Leary, Lead Independent Director, who will replace Mr

    3/26/26 4:06:00 PM ET
    $VTS
    Oil & Gas Production
    Energy

    Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast

    NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the appointment of Teresa Montagut MD, PhD in the newly established position of Head of Clinical Development and Medical Affairs reporting to the Chief Medical Officer Dr. Eric Rose. In this role, Teresa will lead Mesoblast's medical affairs organization, fostering clinical collaborations and spearheading investigator-initiated trials, enhancing clinical and medical communications, and engaging with healthcare professionals. She will play a critical role in unlocking the value of Mesoblast's cell therapy programs i

    3/11/26 7:21:39 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    PENN Entertainment Appoints Three New Independent Directors to Board

    Adds Heather Ace, Jeffrey Fox and Fabio Schiavolin, Bringing Decades of Experience in Global Gaming, Technology, Digital Infrastructure, Finance and Human Resources Enters into Cooperation Agreement with HG Vora PENN Entertainment, Inc. (NASDAQ:PENN) ("PENN" or the "Company") today announced the appointment of three new independent directors, Heather Ace, Jeffrey Fox and Fabio Schiavolin, to its Board of Directors (the "Board"), effective immediately. In connection with these appointments, the Company has entered into a cooperation agreement with HG Vora Capital Management, LLC and certain of its affiliates (collectively, "HG Vora"). David Handler, Chair of PENN's Board, said, "On beh

    2/23/26 7:00:00 AM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    $BUR
    $CIM
    $FTRE
    $KEP
    Financials

    Live finance-specific insights

    View All

    PENN Entertainment to Report First Quarter Results and Host Conference Call and Webcast on April 23

    PENN Entertainment, Inc. (NASDAQ:PENN) announced today that it will release its 2026 first quarter financial results at 7:00 a.m. ET on Thursday, April 23, 2026, followed by a conference call and simultaneous webcast at 8:00 a.m. ET. Both the call and webcast are open to the general public. The conference call number is 785-424-1699 (conference ID: PENN); please call five minutes in advance to ensure that you are connected prior to the presentation. Interested parties may also access the live call at www.pennentertainment.com; allow 15 minutes to register, download, and install any necessary software. Questions and answers will be reserved for call-in analysts and investors. A replay of t

    3/30/26 2:31:00 PM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    Vitesse Energy Announces Hedging Update and Board Member Transition

    Vitesse Energy, Inc. (NYSE:VTS) ("Vitesse" or the "Company") today announced a hedging update related to opportunistic additional hedges through 2027 at price levels that support its dividend, along with the transition of M. Bruce Chernoff from Vitesse's Board of Directors (the "Vitesse Board"). HEDGING UPDATE Vitesse hedges a portion of its expected oil, natural gas, and NGL production volumes to increase the predictability and certainty of its cash flow and to help maintain a strong financial position to support its dividend. In light of the recent commodity price environment, the Company has added substantial hedges and select NGL hedges since it released its fourth quarter and full

    3/13/26 4:06:00 PM ET
    $VTS
    Oil & Gas Production
    Energy

    Vitesse Energy Announces Signing of Accretive Acquisition, Fourth Quarter and Full Year 2025 Results, and Issues 2026 Production and Capital Expenditures Guidance

    Vitesse Energy, Inc. (NYSE:VTS) ("we," "our," "Vitesse," or the "Company") today announced an accretive all-stock acquisition, reported fourth quarter and full year 2025 financial and operating results, and issued 2026 guidance for production and capital expenditures. ACQUISITION Signed a definitive agreement to acquire non-operated assets in the Powder River Basin of Wyoming for $35 million of Vitesse common stock, with an effective date of January 1, 2026 FULL YEAR 2025 HIGHLIGHTS As previously announced, declared a quarterly cash dividend of $0.4375 per common share to be paid on March 31, 2026 Net income of $25.3 million and Adjusted Net Income(1) of $30.4 million Adj

    3/2/26 4:06:00 PM ET
    $VTS
    Oil & Gas Production
    Energy